Authors
Latest:
Despite Slowing Economy, Demand for Pharma Talent RisesPharma companies need to rethink their strategies to ensure that they hire the best available talent in today's market.
Latest:
Almirall’s Garden of InnovationClay Hausmann describes how Almirall is weeding out uncertainty to sow the seeds of data-driven digital transformation.
Latest:
FDA Approves Tremfya for Children With Plaque Psoriasis, Psoriatic ArthritisThe FDA has expanded Johnson & Johnson’s Tremfya (guselkumab) approval to children six years and older weighing at least 40 kilograms with moderate to severe plaque psoriasis or active psoriatic arthritis, marking the first pediatric approval of an IL-23 inhibitor for these conditions.
Latest:
How Pharma Reps and Managers Can Work to Overcome the In-Person HCP BarrierWhile HCPs are turning away from in-person meetings with sales reps amidst the COVID-19 pandemic, there are still strategies for them to keep their pipelines full.
Latest:
Overcoming Hidden Obstacles in the Script-to-Therapy JourneyBy integrating support directly into existing workflows and focusing on solutions that eliminate "shoulder time," manufacturers can significantly reduce delays and improve patient outcomes.
Latest:
Market Access And Treatment OutcomesShifting from the volume of data to the value of insights
Latest:
Lessons Learned Working with Millions of Patients on Specialty MedicationsAdditional assistance necessary for patients prescribed specialty therapies.
Latest:
Addressing Health Disparities Through Robust Patient Support ProgramsIdentifying unique traits in patients is key to creating the most effective support programs.
Latest:
How Cloud-Based Business Management Can Streamline Processes, Manage Reporting Better, and Create Stronger Financial ControlsThursday June 8, 2022 at 11am PDT | 2pm EDT | 7pm BST | 8pm CEST Learn how life sciences companies can navigate growth by leveraging NetSuite for streamlined processes, better management reporting, and stronger financial controls to ensure real-time management decision-making and regulatory compliance.
Latest:
Prospective Measures to Combat Rising Drug Prices in GermanyThis article provides an overview of potential tools being explored in Germany by Health Insurance Funds to better control drug prices and healthcare spend, offering insight into which measure may be implemented.
Latest:
Dynamic Compliance: The Best Defense for PharmaA proactive and tailored compliance department—with the nimbleness to adapt strategies on the fly—is a critical shield for life sciences companies during government investigations.
Latest:
Survey: How Have the Tariffs & Trade Policy Affected the Pharmaceutical Industry?Complete this survey to illustrate how new tariffs and trade policy have impacted you and your organization.
Latest:
Coaching Flag Football—And Guiding a Biotech Through CommercializationUseful tips and parallels for staying in the game following a complete response letter.
Latest:
The Biopharma SME Revolution: Opportunities & Challenges Post-COVIDAhmed Bouzidi explores the opportunities and challenges facing small and mid-size biopharma companies as they strive to bring their latest innovations to market.
Latest:
Taking Steps Toward a Sustainable FutureStrategies to become a Certified B Corporation, and the benefits to the industry, its stakeholders, and the world.
Latest:
How Medical Affairs Can Contribute to Successful Drug LaunchFaster launch planning leads to greater access.
Latest:
Approaching Agentic AI Strategically: Life Sciences Data UtilizationStrategies for biopharma in integrating agentic AI—to achieve incremental gains in efficiency, while delivering meaningful progress in how data insights inform commercial decision-making.
Latest:
COVID-19: Therapeutics Under InvestigationJanita Good looks at some of the therapeutics currently under investigation and the issues they have highlighted in the context of a pandemic.
Latest:
Optimizing next-generation sequencing for precision oncology trialsThis article explores how optimizing next-generation sequencing (NGS) in oncology trials can enhance patient identification, boosts efficiency, and enables diverse recruitment.
Latest:
The Importance of Responsible and Transparent Communications in Pharma MarketingPharma marketing strategies that are both socially and ethically responsible can build long term success for the life sciences industry.
Latest:
Payers Believe Lowering Drug Prices While Improving Patient Access Is Possible—but There’s a CatchValue-based price for access (VBPA) may increase access of specialty drugs for patients.
Latest:
Are You Ready for the Telemedicine Revolution?A new patient journey is emerging. Gilda Sala, Trista Bridges, and Rune Soelvsteen offer easy steps to future-proof your company’s approach.
Latest:
Most Favored Nation Drug Pricing Undermines What Makes America GreatMost Favored Nation drug pricing proposal aims to tie US medicine costs to lower European rates, but experts warn this approach could restrict patient access to lifesaving treatments, slow innovation, and jeopardize future drug development by importing flawed foreign price-control models.
Latest:
Reducing Prescription Drug Costs for Seniors: The ABCs of ASP for Part DOutlining the steps to a payment approach for Medicare Part D drugs that provides savings for patients.
Latest:
Gross-to-Net is not just a process but a way for business growthDefining what Gross-to-Net mean and why it is important to Life Sciences companies; Identify who in the company benefits in utilizing information from GTN; Get insights to successfully define and manage GTN process
Latest:
In life sciences, the metaverse opportunity knocksHere are three mindsets for pharma companies to adopt now to reap the rewards of early action in the metaverse.
Latest:
Executive Presence: The Leadership Edge Pharma Leaders Can't Afford to OverlookUnlock the secrets of executive presence in pharma to inspire confidence, influence decisions, and elevate your leadership impact.
Latest:
Generative AI and Digital Workers: Accelerating Innovation in the Pharma IndustryIf used properly, AI can be a game-changer for drug development.
Latest:
Thriving ‘Beyond the Pill’: Closing Key Gap in Patient SupportWhy pharma needs to focus on improving—not just extending life.
